(NASDAQ:ORIC), SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on August 1, 2025 (the “Grant Date”), ORIC granted a total of 35,000 non-qualified stock options and 5,800 restricted […]
(NYSE:TOL), FORT WASHINGTON, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, will broadcast live on its website, www.TollBrothers.com, a conference call to discuss results for its third quarter ended July 31, 2025. The call is scheduled for 8:30 a.m. (ET) on Wednesday, August 20, 2025
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K GlobeNewswire August 01, 2025 NORWELL, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on July 29, 2025, from the Listing Qualifications Staff of The
WEBUY GLOBAL LTD Announces Closing of Follow-on Offering GlobeNewswire August 01, 2025 Singapore, Aug. 01, 2025 (GLOBE NEWSWIRE) — WEBUY GLOBAL LTD (Nasdaq: WBUY) (“Webuy” or the “Company”), a technology-driven company transforming community e-commerce and travel across Southeast Asia, today announced the closing of its offering of 721,918 Class A ordinary shares and pre-funded warrants
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on August 1, 2025 (the “Grant
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective August 1, 2025, the company granted non-qualified stock options
Toll Brothers to Webcast Its Third Quarter 2025 Earnings Conference Call Live on August 20, 2025 at 8:30 a.m. (ET) GlobeNewswire August 01, 2025 FORT WASHINGTON, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, will broadcast live on its website, www.TollBrothers.com, a conference call to
Sirona Biochem Update to Shareholders on Financial Status and Operations GlobeNewswire August 01, 2025 VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company's financial position and recent corporate developments. The convertible debenture financing announced on April
(NYSE:VSTS), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Vestis Corporation (NYSE: VSTS). Shareholders who purchased shares of VSTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake
Vestis Corporation Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before August 8, 2025 to Discuss Your Rights – VSTS GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Vestis Corporation (NYSE: VSTS). Shareholders who purchased